Guidance

Pertussis vaccine: PGD template

PGD template to support the national pertussis vaccination for pregnant women programme and vaccination of contacts of pertussis in accordance with guidelines.

• From: UK Health Security Agency
• Published: 7 January 2016
• Last updated: 29 May 2024
  Show all updates

  1. 29 May 2024

     Added version 7, see 3 for change history.

  2. 2 March 2023

     Added version 06.00 - see page 3 for change history.

  3. 8 March 2021

     Added version 05.00 - see page 2 for change history.

  4. 11 March 2019

     Added version V04.00 - updated as routine review prior to PGD expiry (see document change history) and included immunisation of contacts of pertussis.

  5. 6 April 2017

     Updated vaccine eligibility changed from 20 weeks to 16 weeks of pregnancy.

  6. 13 April 2016

     Updated pertussis pregnancy PGD: vaccine eligibility changed from 28 to 20 weeks of pregnancy.

  7. 7 January 2016

     First published.

Documents

Pertussis Vaccine Patient Group Direction

Ref: UKHSA gateway number GOV-16448

MS Word Document, 153 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of low dose diphtheria, tetanus and pertussis (Tdap) (or low dose diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) if Tdap clinically unsuitable) to:

• women from 16 weeks of pregnancy, in accordance with the Vaccination against pertussis (whooping cough) for pregnant women programme
• contacts of pertussis, aged 10 years and over, in accordance with Pertussis: guidelines for public health management and Pertussis: guidelines for public health management in a healthcare setting

Pertussis Vaccine Patient Group Direction version 7 is valid from 1 July 2024 to 1 July 2027.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.